GRI Bio (GRI) Assets Average (2021 - 2026)
GRI Bio (GRI) posted quarterly Assets Average of $10.0 million for Q1 2026, up 104.53% year-over-year from $4.9 million in Q1 2025, and up 48.76% quarter-over-quarter from $6.7 million in Q4 2025.
GRI Bio (GRI) Assets Average (2021 - 2026) Analysis & Trends
GRI Bio's Assets Average history runs 6 years deep, the most recent figure standing at $10.0 million for Q1 2026.
- In Q1 2026, Assets Average rose 104.53% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (up 104.53% YoY), while the FY2025 annual figure was $7.2 million, up 65.67% from the prior year.
- Assets Average for Q1 2026 stood at $10.0 million, up from $6.7 million in the prior quarter.
- The five-year high for Assets Average was $10.0 million in Q1 2026, with the low at $1.2 million in Q1 2023.
- The 5-year median for Assets Average is $5.2 million (2025), against an average of $5.3 million.
- The sharpest annual moves came in 2023 and 2024: Assets Average sank 82.63% in 2023, then jumped 204.15% in 2024.
- GRI Bio's Assets Average stood at $3.0 million in 2022, then increased by 23.66% to $3.7 million in 2023, then surged by 52.15% to $5.6 million in 2024, then gained by 20.09% to $6.7 million in 2025, then soared by 48.76% to $10.0 million in 2026.
- Business Quant data shows GRI's Assets Average at $10.0 million in Q1 2026, $6.7 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | GRI Bio | 3.07 Mn | 3.07 Mn | - | 11.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.00 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 4.89 Mn |
| Dec 31, 2024 | 5.60 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 5.02 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 2.98 Mn |
| Sep 30, 2022 | 6.79 Mn |
| Jun 30, 2022 | 6.98 Mn |
| Mar 31, 2022 | 7.14 Mn |
| Dec 31, 2021 | 9.24 Mn |
| Sep 30, 2021 | 10.89 Mn |
| Jun 30, 2021 | 13.12 Mn |